Villadangos J A, Bryant R A, Deussing J, Driessen C, Lennon-Duménil A M, Riese R J, Roth W, Saftig P, Shi G P, Chapman H A, Peters C, Ploegh H L
Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA.
Immunol Rev. 1999 Dec;172:109-20. doi: 10.1111/j.1600-065x.1999.tb01360.x.
Major histocompatibility complex class II antigen presentation requires the participation of lysosomal proteases in two convergent processes. First, the antigens endocytosed by the antigen-presenting cells must be broken down into antigenic peptides. Second, class II molecules are synthesized with their peptide-binding site blocked by invariant chain (Ii), and they acquire the capacity to bind antigens only after Ii has been degraded in the compartments where peptides reside. The study of genetically modified mice deficient in single lysosomal proteases has allowed us to determine their role in these processes. Cathepsins (Cat) B and D, previously considered major players in MHC class II antigen presentation, are dispensable for degradation of Ii and for generation of several antigenic determinants. By contrast, Cat S plays an essential role in removal of Ii in B cells and dendritic cells, whereas Cat L apparently does so in thymic epithelial cells. Accordingly, the absence of Cat S and L have major consequences for the onset of humoral immune responses and for T-cell selection, respectively. It is likely that other as yet uncharacterized lysosomal enzymes also play a role in Ii degradation and in generation of antigenic determinants. Experiments involving drugs that interfere with protein traffic suggest that more than one mechanism for Ii removal, probably involving different proteases, can co-exist in the same antigen-presenting cell. These findings may allow the development of protease inhibitors with possible therapeutic applications.
主要组织相容性复合体II类抗原呈递需要溶酶体蛋白酶参与两个汇聚过程。首先,抗原呈递细胞内吞的抗原必须被分解成抗原肽。其次,II类分子在合成时其肽结合位点被恒定链(Ii)阻断,只有在Ii在肽所在的区室中被降解后,它们才获得结合抗原的能力。对缺乏单一溶酶体蛋白酶的基因修饰小鼠的研究使我们能够确定它们在这些过程中的作用。组织蛋白酶(Cat)B和D,以前被认为是MHC II类抗原呈递的主要参与者,对于Ii的降解和几种抗原决定簇的产生是可有可无的。相比之下,Cat S在B细胞和树突状细胞中去除Ii方面起着至关重要的作用,而Cat L显然在胸腺上皮细胞中发挥这一作用。因此,Cat S和L的缺失分别对体液免疫反应的启动和T细胞选择产生重大影响。很可能其他尚未被鉴定的溶酶体酶也在Ii降解和抗原决定簇的产生中发挥作用。涉及干扰蛋白质转运的药物的实验表明,在同一个抗原呈递细胞中可能共存不止一种去除Ii的机制,可能涉及不同的蛋白酶。这些发现可能有助于开发具有潜在治疗应用的蛋白酶抑制剂。